Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.08.704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2013English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness of Apixaban Compared to Other Anticoagulants in Patients With Atrial Fibrillation in the Real-World and Trial Settings

PLoS ONE
Multidisciplinary
2019English

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open
Medicine
2020English

A Review on a Comparative Study on Effectiveness and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation

International Journal of Pharmaceutical and Biological Science Archive
2019English

Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy